Skip to content
Ipamorelin Telehealth

Who's behind this

About Ipamorelin Telehealth

A plain-English reading list on one peptide. No clinic, no checkout, no prescriptions — just the research, told straight.

What this site is

Ipamorelin Telehealth is a plain-English reading list on the peer-reviewed research literature on Ipamorelin, the ghrelin-receptor peptide. It reads the studies, pulls out what was actually measured, and writes it up so a curious non-scientist can follow — leading with the gut-motility and appetite angle that makes this compound distinctive.

There's no clinic here, no clinical staff, and no medical advice — nothing is manufactured, sold, or shipped, and there's no way to buy anything. It's a reading of published science: a reading list, not a service.

About the name

Yes, the domain says "telehealth." That word here is editorial framing — a nod to how this compound is talked about and accessed online — not a claim that this site offers telehealth, consultations, prescriptions, or any clinical service. It doesn't, and it never will. Treat the name as a signpost for the topic, the same way a magazine titled with a subject isn't the subject itself.

We lead with the "availability" framing only to organize the reading around the questions real people search for: what it does, whether it affects appetite, how it's been dosed in studies, and what the safety picture honestly looks like.

How we handle the evidence

Three rules keep us honest. First, every number is cited — doses, half-lives, trial results, effect sizes all trace to a numbered source on the Ipamorelin references page. Second, we never give human dosing or medical advice; study doses are reported as what researchers gave animals or trial subjects, never as instructions. Third, we separate proof from popularity — community reports are clearly labeled anecdotal on the Ipamorelin effects page, while cited findings stand on their own.

When the evidence is thin — and for ipamorelin's human file, it is — we say so. The one human efficacy trial missed its goal, and we lead with that rather than bury it.